Sukhjit Starch & Chemicals Ltd
Incorporated in 1943, The Sukhjit Starch & Chemicals Ltd is an Agro-Processing company that manufactures starch & its derivatives[1]
- Market Cap ₹ 614 Cr.
- Current Price ₹ 197
- High / Low ₹ 324 / 172
- Stock P/E 15.6
- Book Value ₹ 182
- Dividend Yield 2.03 %
- ROCE 9.64 %
- ROE 7.21 %
- Face Value ₹ 5.00
Pros
- Stock is trading at 1.08 times its book value
Cons
- Company has a low return on equity of 10.6% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
506 | 531 | 565 | 652 | 701 | 741 | 797 | 699 | 1,157 | 1,435 | 1,371 | 1,486 | |
456 | 467 | 504 | 601 | 637 | 648 | 741 | 634 | 1,005 | 1,292 | 1,245 | 1,383 | |
Operating Profit | 50 | 64 | 61 | 50 | 64 | 93 | 57 | 64 | 152 | 143 | 126 | 103 |
OPM % | 10% | 12% | 11% | 8% | 9% | 13% | 7% | 9% | 13% | 10% | 9% | 7% |
2 | 2 | 3 | 2 | 5 | 2 | 8 | 4 | 1 | 2 | 8 | 7 | |
Interest | 17 | 18 | 15 | 13 | 18 | 16 | 18 | 21 | 21 | 25 | 30 | 29 |
Depreciation | 12 | 13 | 12 | 12 | 15 | 13 | 13 | 18 | 25 | 27 | 27 | 28 |
Profit before tax | 23 | 34 | 36 | 28 | 36 | 66 | 33 | 30 | 107 | 93 | 77 | 53 |
Tax % | 29% | 33% | 35% | 33% | 36% | 37% | -1% | 25% | 28% | 24% | 28% | 25% |
16 | 23 | 23 | 19 | 23 | 42 | 34 | 23 | 77 | 70 | 56 | 39 | |
EPS in Rs | 5.42 | 7.84 | 7.79 | 6.42 | 7.78 | 14.13 | 11.36 | 7.66 | 24.77 | 22.48 | 17.83 | 12.64 |
Dividend Payout % | 16% | 16% | 16% | 19% | 21% | 27% | 9% | 20% | 20% | 18% | 22% | 8% |
Compounded Sales Growth | |
---|---|
10 Years: | 11% |
5 Years: | 13% |
3 Years: | 9% |
TTM: | 8% |
Compounded Profit Growth | |
---|---|
10 Years: | 5% |
5 Years: | 7% |
3 Years: | -20% |
TTM: | -23% |
Stock Price CAGR | |
---|---|
10 Years: | 13% |
5 Years: | 18% |
3 Years: | -3% |
1 Year: | -10% |
Return on Equity | |
---|---|
10 Years: | 11% |
5 Years: | 12% |
3 Years: | 11% |
Last Year: | 7% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 7 | 7 | 7 | 7 | 7 | 15 | 15 | 15 | 16 | 16 | 16 | 16 |
Reserves | 174 | 193 | 212 | 235 | 252 | 274 | 306 | 326 | 409 | 469 | 512 | 552 |
177 | 165 | 129 | 106 | 151 | 151 | 281 | 244 | 248 | 301 | 313 | 282 | |
47 | 52 | 61 | 77 | 96 | 92 | 107 | 122 | 109 | 120 | 147 | 155 | |
Total Liabilities | 404 | 418 | 410 | 425 | 507 | 533 | 709 | 706 | 783 | 905 | 987 | 1,005 |
198 | 218 | 221 | 234 | 232 | 234 | 233 | 377 | 381 | 434 | 432 | 454 | |
CWIP | 10 | 5 | 9 | 10 | 14 | 68 | 181 | 67 | 64 | 16 | 29 | 17 |
Investments | 21 | 14 | 25 | 39 | 64 | 93 | 49 | 47 | 104 | 116 | 121 | 91 |
175 | 181 | 154 | 142 | 196 | 138 | 246 | 215 | 234 | 339 | 404 | 443 | |
Total Assets | 404 | 418 | 410 | 425 | 507 | 533 | 709 | 706 | 783 | 905 | 987 | 1,005 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
34 | 63 | 87 | 40 | 13 | 127 | -51 | 90 | 141 | 28 | 66 | 56 | |
-25 | -20 | -31 | -29 | -38 | -94 | -73 | -41 | -103 | -41 | -36 | -0 | |
-4 | -32 | -60 | -21 | 25 | -29 | 125 | -49 | -38 | 13 | -27 | -56 | |
Net Cash Flow | 6 | 12 | -3 | -10 | 0 | 3 | 1 | -0 | 0 | 0 | 3 | 0 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 38 | 38 | 37 | 34 | 37 | 30 | 25 | 33 | 21 | 20 | 21 | 28 |
Inventory Days | 108 | 93 | 55 | 45 | 76 | 45 | 101 | 84 | 49 | 64 | 87 | 72 |
Days Payable | 28 | 28 | 32 | 26 | 30 | 24 | 27 | 34 | 24 | 20 | 28 | 24 |
Cash Conversion Cycle | 117 | 103 | 60 | 53 | 82 | 50 | 99 | 82 | 46 | 65 | 80 | 75 |
Working Capital Days | 83 | 76 | 58 | 52 | 71 | 41 | 76 | 67 | 41 | 59 | 73 | 89 |
ROCE % | 11% | 15% | 14% | 12% | 13% | 19% | 9% | 8% | 20% | 16% | 12% | 10% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
9 Jun - Audio recording of Q4 & FY25 results concall available on company website.
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
31 May - Conference call on June 9, 2025, to discuss Q4 & FY25 financial results.
- Announcement under Regulation 30 (LODR)-Newspaper Publication 31 May
-
Announcement under Regulation 30 (LODR)-Press Release / Media Release
31 May - FY25 revenue grew 8.41% to Rs 1,486 Cr; EBITDA and profit declined; stock split done; expansion ongoing.
-
Appointment Of Secretarial Auditors And Re-Appointment Of Cost Auditors Of The Company
30 May - Appointment of secretarial auditor and re-appointment of cost auditor for FY 2025-26.
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
Concalls
-
Nov 2024TranscriptPPTREC
-
Aug 2024TranscriptPPT
-
Aug 2024TranscriptPPTREC
-
Jun 2024TranscriptPPT
-
Jun 2024TranscriptPPTREC
-
Nov 2023TranscriptPPTREC
-
Jun 2023Transcript PPT REC
-
Dec 2019TranscriptNotesPPT
-
Feb 2019TranscriptNotesPPT
Business Overview:[1]
SSCL is a part of the Sardana family and associates. The company primarily manufactures starch, its derivatives, and
other by-products.